• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION REZUM; UNIT, ELECTROSURGICAL ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION REZUM; UNIT, ELECTROSURGICAL ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES) Back to Search Results
Model Number D2201
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Endocarditis (1834); Fever (1858); Necrosis (1971); Sepsis (2067); Urinary Tract Infection (2120)
Event Date 09/01/2021
Event Type  Injury  
Manufacturer Narrative
Date of event: the exact event date is unknown.
 
Event Description
It was reported that the patient underwent a water vapor therapy procedure in mid (b)(6) 2021.A total of seven treatments were administrated.Three treatments were delivered to the prostate left lobe, three to the right lobe and one to the middle lobe.The symptoms post procedure were normal, and the patient had a strong flow of urine.However, the patient experienced an urinary tract infection (uti) and fever.The patient presented to primary care physician and then followed up with his urologist for antibiotics and medications.After several weeks, the patient returned with fever to the emergency room.A computed axial tomography (cat) scan was performed and showed what was believed to be an abscess in the prostate.Upon attempted drainage, no infection or fluid was removed, but necrotic tissue was observed.The patient experienced prolonged bacteremia/urosepsis which resulted in endocarditis.The patient is currently awaiting an aortic valve repair due to the endocarditis from prolonged bacteremia.
 
Event Description
It was reported that the patient underwent a water vapor therapy procedure in (b)(6) 2021.A total of seven treatments were administrated.Three treatments were delivered to the prostate left lobe, three to the right lobe and one to the middle lobe.The symptoms post procedure were normal, and the patient had a strong flow of urine.However, the patient experienced an urinary tract infection (uti) and fever.The patient presented to primary care physician and then followed up with his urologist for antibiotics and medications.After several weeks, the patient returned with fever to the emergency room.A computed axial tomography (cat) scan was performed and showed what was believed to be an abscess in the prostate.Upon attempted drainage, no infection or fluid was removed, but necrotic tissue was observed.The patient experienced prolonged bacteremia/urosepsis which resulted in endocarditis.The patient is currently awaiting an aortic valve repair due to the endocarditis from prolonged bacteremia.
 
Manufacturer Narrative
B3 date of event: the exact event date is unknown.Investigation summary: based on the information available, there was no device available for analysis and there was no report of a device performance allegation during treatment.The reported patient symptoms are known risks associated with water vapor therapy procedures and are noted as such in the device instructions for use.Device history record (dhr): a dhr and ship history review cannot be performed as the lot number was not available.Device technical analysis: the device is not available for analysis; therefore, no physical or visual analysis of the product could be performed.The reported device performance allegation cannot be confirmed.Labeling review: the device instructions for use (ifu) and hazard analysis were reviewed.The patient symptoms of urinary infection, fever, abscess, necrosis and sepsis were found to be listed in the risk documentation.Investigation conclusion: based on the information available, a conclusion code of known inherent risk of device was assigned to this investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REZUM
Type of Device
UNIT, ELECTROSURGICAL ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer Contact
alyson harris
4100 hamline avenue north
building c
saint paul, MN 55112
4089353452
MDR Report Key12691101
MDR Text Key278201106
Report Number2124215-2021-32179
Device Sequence Number1
Product Code KNS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K180237
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/25/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD2201
Device Catalogue NumberD2201
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/05/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Other;
Patient Age69 YR
Patient SexMale
-
-